Humana (NYSE:HUM) Issues FY24 Earnings Guidance

Humana (NYSE:HUM) updated its FY24 earnings guidance on Wednesday. The company provided EPS guidance of at least $16.00 for the period, compared to the consensus EPS estimate of $16.17. Humana also updated its FY 2024 guidance to 16.000- EPS.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Oppenheimer dropped their price target on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research report on Thursday, October 3rd. Stephens restated an “equal weight” rating and issued a $250.00 price target on shares of Humana in a research report on Wednesday, October 9th. Jefferies Financial Group lowered Humana from a “buy” rating to a “hold” rating and lowered their price objective for the company from $519.00 to $253.00 in a report on Monday, October 7th. Barclays lifted their price objective on Humana from $250.00 to $253.00 and gave the company an “equal weight” rating in a report on Thursday. Finally, Sanford C. Bernstein raised Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price objective on the stock in a report on Tuesday, October 8th. One investment analyst has rated the stock with a sell rating, nineteen have assigned a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $315.48.

Humana Price Performance

HUM stock traded up $2.88 on Friday, reaching $260.71. The company had a trading volume of 1,396,968 shares, compared to its average volume of 1,856,202. Humana has a 1 year low of $213.31 and a 1 year high of $527.18. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.66 and a current ratio of 1.76. The company’s fifty day moving average is $297.06 and its 200 day moving average is $334.38. The company has a market cap of $31.39 billion, a P/E ratio of 23.09, a PEG ratio of 2.07 and a beta of 0.50.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The firm had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. On average, research analysts forecast that Humana will post 16.06 earnings per share for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.36%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s payout ratio is currently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.